General Biologicals Corp. engages in research, development, manufacture and trade of diagnostics and pharmaceuticals. The company provides anti-bacterial peptide in the areas of pharmaceutical, cosmetics, and oral products. Its products include COVID-19 and digital pathology solutions, in vitro diagnostic (IVD) kits & system, HIV ELISA blood screening, human plasma and antibody biomaterials. The company was founded on June 11, 1984 and is headquartered in Hsinchu, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company